Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002)
Clinical trial NCT00777959 · COMPLETED
Trial details
- NCT number
- NCT00777959
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Primary completion
- 2011-05-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.